The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with ...

The RSV vaccine is specifically created and approved for administration in older adults. Back in March, the FDA recommended ...

RSV is a leading cause of infant hospitalizations in Canada, with older people and those who are immunocompromised also at greater risk ...

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater numbers of babies and toddlers to the hospital for professional care.

ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ transplant, a group that is at an increased risk for severe infection, ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

The adjusted incident rate ratio (IRR) for GBS post-RSV disease was 2.11, reflecting a slightly more than double risk. The ...

The respiratory virus season has just begun, and the best way to protect yourself is by getting immunized against flu, COVID-19 and respiratory syncytial virus or RSV. Updated COVID-19 and flu ...